Myriad Genetics reported $-65700000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agilent A:US $ 493M 50M
Becton, Dickinson and BDX:US $ 1368M 274M
Bio Rad Laboratories BIO:US $ 196.9M 46.12M
Biocept BIOC:US $ 0.87M 2.28M
Bruker BRKR:US $ 137.2M 25.2M
Danaher DHR:US $ 1863M 667M
Exact Sciences EXAS:US $ -95.57M 30.77M
Fluidigm FLDM:US $ -15.62M 2.47M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Hologic HOLX:US $ 578.2M 114.8M
Illumina ILMN:US $ -414M 650M
Johnson & Johnson JNJ:US $ 8192M 2043M
Luminex LMNX:US $ 21.3M 3.09M
Mettler Toledo International MTD:US 287.25M 18.01M
Myriad Genetics MYGN:US $ -65.7M 63.6M
Oxford Immunotec Global OXFD:US $ 0.79M 10.16M
Pacific Biosciences Of California PACB:US $ -43.63M 7.65M
Perkinelmer PKI:US $ 375.02M 48.76M
Quest Diagnostics DGX:US $ 766M 112M
Quidel QDEL:US $ 294.63M 255.81M
Repligen RGEN:US $ 59.7M 2.24M
Thermo Fisher Scientific TMO:US $ 2924M 24M
Veracyte VCYT:US $ -36.04M 41.77M
Waters WAT:US $ 223.62M 6.35M